Zobrazeno 1 - 10
of 139
pro vyhledávání: '"James L Slack"'
Autor:
Pierre Noel, James L. Slack, Luke Mountjoy, Jose F. Leis, Lisa Z. Sproat, Jeanne Palmer, Katie L. Kunze, Tania Jain, Nandita Khera
Publikováno v:
Leukemia & Lymphoma. 62:252-254
Allogenic stem cell transplantation (HCT) is a potentially curative treatment for patients with various hematologic malignancies. Following HCT it is common practice to assess peripheral blood sort...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e38d920b00051c8c9c0dde0490d368a0
https://doi.org/10.1080/10428194.2020.1827249
https://doi.org/10.1080/10428194.2020.1827249
Autor:
Luke Mountjoy, Jose F. Leis, Nandita Khera, James L. Slack, Katie L. Kunze, Jeanne Palmer, Woodburn Jennifer, Lisa Z. Sproat, Tania Jain, Margaret McCallen, Pierre Noel
Publikováno v:
Leukemialymphoma. 61(8)
Anti-thymocyte globulin (ATG) has been associated with decreased rates graft versus host disease (GVHD) but with a potential risk of increasing risk of infection and relapse. We retrospectively studied the impact of single dose low dose (2.5 mg/kg) A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497208fbf835cf05f4304f9594a00ed2
https://pubmed.ncbi.nlm.nih.gov/32281491
https://pubmed.ncbi.nlm.nih.gov/32281491
Autor:
Jose F. Leis, Katie L. Kunze, Nandita Khera, Vivek Roy, Tania Jain, Mrinal M. Patnaik, William J. Hogan, Heidi E. Kosiorek, Pierre Noel, Jeanne Palmer, Ruben A. Mesa, Lisa Sproat, Luke Mountjoy, Daniel K. Partain, James L. Slack, Veena Fauble, Ayalew Tefferi
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 3, Pp 1-8 (2020)
Blood Cancer Journal, Vol 10, Iss 3, Pp 1-8 (2020)
Factors predicting allogeneic hematopoietic cell transplantation (HCT) outcomes in myelofibrosis in the early post-HCT period have not been defined thus far. We attempt to study such factors that can help identify patients at a higher risk of relapse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31dd72132fde25129bdf2df544af0397
http://europepmc.org/articles/PMC7064504
http://europepmc.org/articles/PMC7064504
Autor:
Courtney D. DiNardo, Hua Liu, Gail J. Roboz, Hongfang Wang, Martha Arellano, Samuel V. Agresta, Vickie Zhang, Ronan T. Swords, Martin S. Tallman, Geoffrey L. Uy, William B. Donnellan, David Dai, Stephanie M. Kapsalis, Christophe Willekens, Jessica K. Altman, James M. Foran, A. Pigneux, Meredith Goldwasser, Sung Choe, Gabriel N. Mannis, Eyal C. Attar, James L. Slack, Amir T. Fathi, Harry P. Erba, Bin Wu, Bin Fan, Robert K. Stuart, S. de Botton, Hagop M. Kantarjian, Richard Stone, Mikkael A. Sekeres, Katharine E. Yen, Hua Yang, Elie Traer, Eytan M. Stein, Robert H. Collins, Alice S. Mims, Daniel A. Pollyea, Anthony S. Stein, Gabrielle T. Prince
Publikováno v:
New England Journal of Medicine. 378:2386-2398
Mutations in the gene encoding isocitrate dehydrogenase 1 ( IDH1) occur in 6 to 10% of patients with acute myeloid leukemia (AML). Ivosidenib (AG-120) is an oral, targeted, small-molecule inhibitor of mutant IDH1.We conducted a phase 1 dose-escalatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::813d58b38d19e9543b4e00255d52453d
https://doi.org/10.1056/nejmoa1716984
https://doi.org/10.1056/nejmoa1716984
Autor:
Katie L. Kunze, Tania Jain, Daniel K. Partain, William J. Hogan, M'hamed Temkit, Veena Fauble, Lisa Z. Sproat, Vivek Roy, Jeanne Palmer, Mrinal S. Patnaik, Pierre Noel, James L. Slack, Jose F. Leis, Nandita Khera, Ruben A. Mesa
Publikováno v:
Bone Marrow Transplant
The aim of this study is to compare clinical outcomes of patients who underwent allogeneic stem cell transplantation (HCT) for myelofibrosis with reduced intensity conditioning (RIC) using either Busulfan Fludarabine (BuFlu), Fludarabine Bis-chloreth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a012cd8a0ac91bc9778f02cff6fccc2
https://doi.org/10.1038/s41409-018-0226-1
https://doi.org/10.1038/s41409-018-0226-1
Autor:
Ayalew Tefferi, Rhett P. Ketterling, Daniel K. Partain, James L. Slack, Mark L. Litzow, William J. Hogan, Mrinal M. Patnaik, Vivek Roy, Jeanne Palmer
Publikováno v:
American Journal of Hematology. 93:649-654
The prognostic importance of genetic information in primary myelofibrosis (PMF) was recently highlighted in a study of over 1000 cytogenetically-annotated patients; 5-year survival rates were 8% for very high risk (VHR), 27% "unfavorable" and 45% "fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a96ef3fc207f3a1918ddea7de5aec7c
https://doi.org/10.1002/ajh.25053
https://doi.org/10.1002/ajh.25053
Autor:
Jose F. Leis, Pierre Noel, James L. Slack, Justin Tai, Jeanne Palmer, Matthew R. Buras, Lisa Sproat
Publikováno v:
Bone Marrow Transplantation. 55:1175-1177
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a925ce7a9a55ba409c66ac39482d5f8
https://doi.org/10.1038/s41409-019-0648-4
https://doi.org/10.1038/s41409-019-0648-4
Autor:
Pierre Noel, Henry Ofori, Margaret McCallen, Lisa Z. Sproat, Jeffrey Betcher, James L. Slack, Tania Jain, Jeanne Palmer, Jose F. Leis, Nandita Khera, Banveet K. Khetarpal, Katie L. Kunze
Publikováno v:
Leukemialymphoma. 60(8)
Therapeutic dose monitoring is widely adopted for determination of busulfan (Bu) dose for use as a conditioning regimen. However, while dose adjustments are being incorporated, transient fluctuations of Bu levels may occur. We aim to understand if th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8819c74de299c7aa39a0a5c5d4a7ad68
https://pubmed.ncbi.nlm.nih.gov/30626239
https://pubmed.ncbi.nlm.nih.gov/30626239
Autor:
Paul E. Andrews, Elzbieta Lenkiewicz, Melissa L. Stanton, Smriti Malasi, Lance C. Pagliaro, Alan H. Bryce, Michael T. Barrett, James L. Slack
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0213815 (2019)
PLoS ONE
PLoS ONE
Testicular germ cell tumors (TGCTs) are unique amongst solid tumors in terms of the high cure rates using chemotherapy for metastatic disease. Nevertheless, TGCTs still kill approximately 400 men per year, at a median age of 30 years, in the United S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba3904625dd42de9e9eea12436b1a9d
https://doaj.org/article/04df792c12f24c8f9e6acb60a5b91bfa
https://doaj.org/article/04df792c12f24c8f9e6acb60a5b91bfa
Autor:
Jaime Rogers, Hannah McNally, Lisa Sproat, Matthew R. Buras, Luke Mountjoy, James L. Slack, Margaret McCallen, Jeanne Palmer, Jose F. Leis, Nandita Khera
Publikováno v:
Journal of Clinical Oncology. 39:e19023-e19023
e19023 Background: Acute GVHD (aGVHD) is a major cause of mortality and morbidity following stem cell transplantation (HCT). In effort to prognostic patients with aGVHD, the Mount Sinai Acute GVHD International Consortium (MAGIC) combined two biomark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cf2988c1a94cc5c9578786088c1145c
https://doi.org/10.1200/jco.2021.39.15_suppl.e19023
https://doi.org/10.1200/jco.2021.39.15_suppl.e19023